Life Style

Vireo Health International Inc: $2.26 U.S. Pot Stock With Great Upside

wp:image {“align”:”left”,”id”:156183,”width”:256,”height”:170,”sizeSlug”:”large”}

/wp:image

wp:heading

Vireo Stock a Tiny Pot Play With High Aspirations

/wp:heading

wp:paragraph

Optimism for the cannabis sector in the U.S. is picking up steam as more states get on board to legalize medical and recreational marijuana.

/wp:paragraph

wp:paragraph

A compelling high-risk micro-cap play on medical and recreational pot in the U.S. that offers a strong risk/reward prospect is Vireo Health International Inc (CNSX:VREO, OTCMKTS:VREOF).

/wp:paragraph

wp:paragraph

Vireo is in its early stages, but it’s displaying a strong ramp-up in its revenues that’s expected to continue.

/wp:paragraph

wp:paragraph

The company does everything from research and development to cultivation, distribution, and retail sales. Vireo Health International Inc has a presence in Arizona, Maryland, Minnesota, New Mexico, and New York. And it’s expanding.

/wp:paragraph

wp:heading

VREOF Stock’s Price Weakness Presents an Opportunity

/wp:heading

wp:paragraph

A look at the following chart shows the amazing move by Vireo stock over the past year after declining to $0.20 during the March 2020 sell-off.

/wp:paragraph

wp:paragraph

VREOF stock’s journey back up has been spectacular, with the stock easily recovering to its pre-COVID-19 levels, up 382% over the past year and up 55% this year.

/wp:paragraph

wp:image {“align”:”center”,”id”:156107,”sizeSlug”:”large”}

/wp:image

wp:paragraph {“className”:”has-text-align-center”}

Chart courtesy of StockCharts.com

/wp:paragraph

wp:paragraph

Vireo stock has pulled back by 35% over the past three months to a level where I see an aggressive opportunity.

/wp:paragraph

wp:heading

Vireo Health International Inc Ramping Up Its Revenues

/wp:heading

wp:paragraph

While it’s early in the cycle for Vireo Health International Inc, the company has been driving its revenues up in its first two years of results.

/wp:paragraph

wp:paragraph

Vireo’s revenues jumped 64.3% year-over-year to $49.2 million in 2020. (Source: “Vireo Health International, Inc. (VREOF),” Yahoo! Finance, last accessed May 10, 2021.)

/wp:paragraph

wp:paragraph

Its revenues will likely accelerate as more cannabis stores open and third-party sales rise. For 2021, the company is expected to increase its revenues by 47.5% to $72.6 million.

/wp:paragraph

wp:paragraph

As Vireo increases its revenues, it’s not surprising to see the company consistently report losses in terms of generally accepted accounting principles (GAAP) earnings per share (EPS).

/wp:paragraph

wp:html

Fiscal Year GAAP Diluted EPS Growth
2017 -$0.01 N/A
2018 -$0.02 -52.0%
2019 -$0.94 -6,108%
2020 -$0.32 66.6%

/wp:html

wp:paragraph

(Source: “Vireo Health International Inc.” MarketWatch, last accessed May 10, 2021.)

/wp:paragraph

wp:paragraph

The company has also been reporting negative earnings before interest, taxes, depreciation, and amortization (EBITDA).

/wp:paragraph

wp:paragraph

What you want to see is narrower losses and a pathway toward profitability.

/wp:paragraph

wp:paragraph

The consensus estimate calls for Vireo to narrow its adjusted loss to $0.06 per diluted share in 2021. The company could see profitability by 2022. (Source: Yahoo! Finance, op. cit.)

/wp:paragraph

wp:paragraph

In the meantime, Vireo Health International Inc will need capital to expand its growing capacity and retail distribution.

/wp:paragraph

wp:paragraph

At the end of 2020, the company’s working capital was strong. Vireo had cash of $25.5 million and debt of $23.2 million. (Source: Yahoo! Finance, op. cit.)

/wp:paragraph

wp:heading

Analyst Take

/wp:heading

wp:paragraph

Vireo Health International Inc is just beginning to ramp up its revenues and expand its retail network. The big risk for the company will be competition and the ability to control its cost side.

/wp:paragraph

wp:paragraph

Of course, the payoff could be massive for a small company like Vireo as the U.S. pot market grows.

/wp:paragraph

 

Source: Vireo Health International Inc: $2.26 U.S. Pot Stock With Great Upside

Related Articles

Check Also
Close
Back to top button